A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
Abstract Aldosterone antagonists slow the progression of chronic kidney disease (CKD), but their use is limited by hyperkalemia, especially when associated with RAS inhibitors. We examined the renoprotective effects of Ly, a novel non-steroidal mineralocorticoid receptor (MR) blocker, through two ex...
Enregistré dans:
Auteurs principaux: | Clarice K. Fujihara, M. C. Kowala, M. D. Breyer, Claudia R. Sena, Mariliza V. Rodrigues, Simone C. A. Arias, Camilla Fanelli, Denise M. Malheiros, P. K. Jadhav, Chahrzad Montrose-Rafizadeh, Jose E. Krieger, Roberto Zatz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/780f96a202214d06a07005c8f676b540 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model
par: Camilla Fanelli, et autres
Publié: (2017) -
[85] Laparoscopic donor nephrectomy
par: Abraham Vinod Peedikayil
Publié: (2018) -
Aldosterone Modulates the Association between NCC and ENaC
par: Brandi M. Wynne, et autres
Publié: (2017) -
Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
par: Scott M. MacKenzie, et autres
Publié: (2021) -
Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism
par: Ariadni Spyroglou, et autres
Publié: (2021)